文献速递重症综合管理与镇静镇痛

ICU远程医疗实施与日间和夜间覆盖下风险校正死亡率差异

ICU Telemedicine Implementation and Risk-Adjusted Mortality Differences Between Daytime and Nighttime Coverage.
PubMed 文献 · Chest · 2020-10-28
一句话结论回顾性前后对照显示,ICU远程医疗实施后风险校正ICU死亡率从8.7%降至6.5%,死亡下降主要驱动于pm(夜间)入院组(10.8%→7.0%)。

该研究为单中心回顾性前后对照分析,比较ICU远程医疗实施前后风险校正ICU死亡率。实施后APACHE IVa评分显著更高(am组46.6 vs 54.8,pm组47.2 vs 56.3,均P<.01)。总体风险校正ICU死亡率8.7%降至6.5%(P<.01);am组无显著差异,pm组10.8%降至7.0%(P<.01)。实施前pm组SMR为1.30,am组为0.95。

要点

  • 总体风险校正ICU死亡率从实施前8.7%降至实施后6.5%(P<.01)。
  • 死亡下降主要见于pm(夜间)入院组:风险校正死亡率10.8%降至7.0%(P<.01)。
  • am(日间)入院组实施前后风险校正ICU死亡率无显著差异。
  • 实施前SMR:am组0.95,pm组1.30;作者提示SMR>1可能与远程医疗带来的死亡下降相关。
  • 实施后两组APACHE IVa评分均显著升高(am 46.6→54.8,pm 47.2→56.3,P<.01)。

适用人群与场景

  • ICU患者-住院,按am与pm入院分组;单中心回顾性分析。

诊断标准与关键阈值

  • 以风险校正ICU死亡率为结局指标;采用APACHE IVa评分进行风险校正。
  • 以实施前SMR(am组0.95,pm组1.30)描述实施前观察值与期望值之比。

处置流程与药物剂量

  • 原文未提及具体远程医疗干预方案、药物剂量或处置流程。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 平均APACHE IVa评分:am组实施前46.6 vs 实施后54.8(P<.01);pm组实施前47.2 vs 实施后56.3(P<.01)。
  • 总体风险校正ICU死亡率:实施前8.7% vs 实施后6.5%(P<.01)。
  • am组风险校正ICU死亡率实施前后无显著差异;pm组实施前10.8% vs 实施后7.0%(P<.01)。
  • 实施前SMR:am组0.95,pm组1.30。

证据类型、等级与局限

  • 证据类型:单中心回顾性前后对照研究;原文未给出证据等级或推荐强度。
  • 局限:回顾性设计、单中心、前后对照、可能存在时间趋势等混杂;作者指出需未来研究确认SMR>1与死亡下降的关联。

对床旁实践的改变

  • 对夜间(pm)入院、实施前SMR>1的ICU,实施远程医疗可能降低风险校正ICU死亡率;日间(am)入院组未见显著获益。
  • 原文未提及具体适用/不适用人群及操作细节,不能据此推断药物或流程推荐。

指南或共识出处

  • Chest(原文未提及具体指南或共识名称及年份)

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: ICU telemedicine augmentation has been associated with improvements in clinical and financial outcomes in many cases, but not all. Understanding this discrepancy is of interest given the clinical impact and intervention cost. A recent meta-analysis noted an association with mortality reduction and standardized mortality ratio (SMR) before ICU telemedicine implementation of > 1.

RESEARCH QUESTION: Does ICU telemedicine implementation affect adjusted mortality outcomes? If so, in what context?

STUDY DESIGN AND METHODS: We performed a retrospective pre-post analysis comparing before vs after ICU telemedicine implementation on the outcome of risk-adjusted ICU mortality during am vs pm admissions as well as other objective measures of ICU telemedicine involvement.

RESULTS: One thousand five hundred eighty-one patient-stays and 14,584 patient-stays were available for analysis in the implementation period before vs after ICU telemedicine implementation, respectively. The average Acute Physiology and Chronic Health Evaluation (APACHE) IVa score was 46.6 vs 54.8 (P < .01) in the am group before ICU telemedicine implementation vs the am group after ICU telemedicine implementation, respectively. The average APACHE IVa score was 47.2 vs 56.3 (P < .01) in the pm group before ICU telemedicine implementation vs the pm group after ICU telemedicine implementation, respectively. Overall, the risk-adjusted ICU mortality was 8.7% before ICU telemedicine implementation vs 6.5% (P < .01) after implementation. When stratified by am and pm admission groups, no significant difference in risk-adjusted ICU mortality was seen in the am stratum. In the pm stratum, risk-adjusted mortality was 10.8% before ICU telemedicine implementation vs 7.0% (P < .01) after ICU telemedicine implementation. The preimplementation SMR in the am admission stratum was 0.95 vs 1.30 in the pm stratum.

INTERPRETATION: We found a reduction in risk-adjusted ICU mortality with implementation of ICU telemedicine driven predominantly within the pm admission group. The pm admission SMR was 1.30, which may suggest an association with SMR of > 1 before ICU telemedicine implementation and mortality reduction. Future studies should seek to confirm this finding and should explore other important ICU telemedicine outcomes in the context of observed-to-expected ratios.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Fusaro MV, Becker C, Miller D, et al. ICU Telemedicine Implementation and Risk-Adjusted Mortality Differences Between Daytime and Nighttime Coverage. Chest. 2020. PMID: 33127432. doi:10.1016/j.chest.2020.10.055

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。